文献速递儿童心血管与肾脏儿童神经与发育行为

儿童心脏移植围术期适应障碍、情绪与焦虑障碍及心室辅助装置支持的关联

Disorders of Adjustment, Mood, and Anxiety in Children and Adolescents Undergoing Heart Transplantation and the Association of Ventricular Assist Device Support.
PubMed 文献 · J Pediatr · 2019-11-12

该研究纳入1999-2016年3073例儿童心脏移植受者,评估移植住院期间精神障碍及治疗的发生率。14.1%患者存在精神障碍,适应障碍最常见,6.9%使用抗抑郁药;精神障碍诊断和抗抑郁药使用随时间增加。需要心室辅助装置支持与精神障碍诊断及抗抑郁药治疗独立相关。

要点

  • 儿童心脏移植住院期间14.1%存在精神障碍,适应障碍最常见。
  • 精神障碍诊断和抗抑郁药使用在2010-2016年较1999-2009年增加。
  • 需心室辅助装置支持者精神障碍诊断和抗抑郁药治疗风险更高。

核心结论

  • 儿童心脏移植受者精神障碍常见,尤其在以心室辅助装置支持过渡的患者中。
  • 精神障碍诊断和抗抑郁药使用随时间增加,可能反映对该脆弱人群精神共病的识别改善。

研究设计与样本

  • 回顾性队列研究,纳入1999-2016年所有儿童心脏移植受者,数据来自关联的管理与临床注册数据库。
  • 共纳入3073例儿童心脏移植受者,使用国际疾病分类或计费代码识别移植住院期间的精神障碍及相关治疗。
  • 采用标准描述性统计和多变量 logistic 回归分析精神障碍或治疗的独立相关因素。

主要发现

  • 434例(14.1%)患者在心脏移植住院期间存在精神障碍,适应障碍最常见。
  • 212例(6.9%)患者接受抗抑郁药治疗,选择性5-羟色胺再摄取抑制剂最常用。
  • 精神障碍诊断从1999-2009年的8.4%增至2010-2016年的18.1%(P < .001)。
  • 抗抑郁药使用从1999-2009年的4.5%增至2010-2016年的8.9%(P < .001)。
  • 需要心室辅助装置支持的患者中,≥8岁者39.8%存在精神障碍。

关键数值与推荐

  • 心室辅助装置支持需求与精神障碍诊断独立相关(aOR,1.57;95% CI,1.18-2.1;P = .002)。
  • 心室辅助装置支持需求与抗抑郁药治疗独立相关(aOR,2.11;95% CI,1.43-3.12;P < .001)。

临床怎么用

  • 儿童心脏移植团队应将精神科服务纳入多学科管理,尤其对需心室辅助装置支持过渡的患者。
  • 移植住院期间应常规筛查适应障碍、情绪和焦虑障碍,并关注抗抑郁药使用情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the prevalence of psychiatric disorders and associated therapies in children during their heart transplantation admission. STUDY DESIGN: All pediatric heart transplant recipients (1999-2016) were included from a linked administrative and clinical registry database. Psychiatric disorders and associated therapies were identified using International Classification of Diseases or billing codes during the transplant admission. Data were analyzed using standard descriptive statistics. Multivariable logistic regression assessed factors independently associated with psychiatric disorders or therapies. RESULTS: A total of 3073 pediatric heart transplant recipients were included. Psychiatric disorders were present in 434 (14.1%) patients during the heart transplant admission, with adjustment disorders being the most common. Antidepressant therapy was prescribed to 212 patients (6.9%) and selective serotonin reuptake inhibitors were most commonly used. Psychiatric diagnoses (8.4% vs 18.1%; P < .001) and the use of antidepressants (4.5% vs 8.9%; P < .001) increased over time (era 1, 1999-2009 vs era 2, 2010-2016). Psychiatric disorders were present in 39.8% of patients ≥8 years of age requiring ventricular assist device support at heart transplantation. The need for ventricular assist device support was independently associated with psychiatric diagnoses (aOR, 1.57; 95% CI, 1.18-2.1; P = .002) and antidepressant therapy (aOR, 2.11; 95% CI. 1.43-3.12; P < .001). CONCLUSIONS: Psychiatric disorders are common in pediatric heart transplant recipients, especially among those bridged with ventricular assist device support. Psychiatric diagnoses and the use of antidepressants has increased over time, likely representing improved recognition of psychiatric comorbidities in this vulnerable population. Access to psychiatric services represents an important component of the multidisciplinary team caring for pediatric heart transplant recipients.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Diaz I, Thurm C, Hall M, et al. Disorders of Adjustment, Mood, and Anxiety in Children and Adolescents Undergoing Heart Transplantation and the Association of Ventricular Assist Device Support. J Pediatr. 2019. PMID: 31732131. doi:10.1016/j.jpeds.2019.10.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。